Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001816338-20-000001
Filing Date
2020-06-29
Accepted
2020-06-29 10:41:50
Documents
1
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 4340
  Complete submission text file 0001816338-20-000001.txt   5772
Mailing Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address 44 SOUTH MAIN STREET 3RD FLOOR HANOVER NH 03755
Business Address
ANDERSON ERRIK (Reporting) CIK: 0001816338 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55939 | Film No.: 20996197